Suspended

PETHOXICOEvaluation of the Threshold for the Interpretation of the Results of a Method for the Blood Determination of Phosphatidyléthanol

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Collected from today forward - Prospective
Who is being recruted

Alcoholism+2

+ Mental Disorders

+ Substance-Related Disorders

Over 18 Years
+5 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Cohort

Tracking disease incidence in order to identify risk factors and understand disease progression over time.
Observational
Study Start: September 2021
See protocol details

Summary

Principal SponsorUniversity Hospital, Lille
Study ContactOlivier COTTENCIN, MD,PhD
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: September 1, 2021

Actual date on which the first participant was enrolled.

For an analytical validation of the method for the determination of blood hosphatidylethathanol, it is necessary to: * to compare the results of chronic and excessive ethanol patients with the cut-off proposed in the literature. * Also assess the stability of phosphatidylethanol in total blood collected, and in blotted dried blood stains (DBS), depending on temperature (ambient temperature and +4°C)

Official TitleEvaluation of the Threshold for the Interpretation of the Results of a Method for the Blood Determination of Phosphatidyléthanol
NCT04557631
Principal SponsorUniversity Hospital, Lille
Study ContactOlivier COTTENCIN, MD,PhD
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

30 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Cohort

These studies follow a group of individuals with common characteristics (such as a condition or birth year) over a specific period to study health outcomes or exposures.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

AlcoholismMental DisordersSubstance-Related DisordersAlcohol-Related DisordersChemically-Induced Disorders

Criteria

2 inclusion criteria required to participate
Person with alcohol consumption ≥ 40g/day (women) and ≥ 60g/day (men) according to WHO criteria
Person hospitalized for a hospital withdrawal in the addiction service of Lille's hospital, without other distinctions.
3 exclusion criteria prevent from participating
Patient opposing the use of their personal data in the study
Patient subject to protective measures (guardianship or curatorship)
Person deprived of liberty

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.
This study has no location dataSave this study to your profile to know when the location data is available.
SuspendedNo study centers